Fate Therapeutics Officers Sell Shares Amid Market Volatility.

lunes, 12 de enero de 2026, 4:06 pm ET1 min de lectura
FATE--

FATE Therapeutics Inc. has announced that Chief Legal and Compliance Officer Cindy Tahal has sold 10,589 shares at a price of $1.06 per share on January 9, 2026. Additionally, Director, President and CEO Bahram Valamehr has sold 5,190 shares at a price of $1.07 per share on the same date.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios